DIR-213 Clinical trial of a genetically modified human adenovirus for treatment of melanoma

Page 1 of 6

Closes 6 May 2025

Contact Information

1. What is your name?
2. What is your email address?

(we will use this to let you know how your submission was considered in the final RARMP)